Skip to content

Immuno-Oncology Summit Europe 2023

Immuno-Oncology Summit Europe 2023

Immuno-Oncology Summit Europe 2023

Immuno-Oncology Summit Europe 2023

📢 Scailyte is thrilled to announce our attendance at the Immuno-Oncology Summit Europe 2023 in London! 🌟🌍

Scheduled for 20-22 June, this highly anticipated event brings together experts and innovators in the field of immuno-oncology to discuss the latest advancements and breakthrough therapies. We’re proud to be part of this prestigious summit and contribute to the dialogue shaping the future of cancer treatment. 💪💉

Our esteemed team members, Diana Stoycheva (Principal Expert Scientist), Sukalp Muzumdar (Senior Data Scientist), and Filipa Teixeira (Business Development Associate), will be in attendance. We’re particularly excited about Diana’s 30-minute presentation on “Enabling Precision Medicine by Combining Multi-Omics Analysis and Artificial Intelligence” on 21 June at 4:40 PM BST. 🎙️🧬

The Immuno-Oncology Summit Europe features an impressive lineup of keynote speakers, engaging breakout discussions, and a diverse faculty representing both industry and academia. It’s a unique opportunity to connect with peers, exchange ideas, and forge collaborations that can accelerate the development of immunotherapies. 🤝💡

At Scailyte, we’re eager to immerse ourselves in the rich scientific discussions, explore cutting-edge advancements, and network with fellow experts in the immuno-oncology field. Together, we aim to advance the boundaries of precision medicine and revolutionize cancer treatment. 🚀💙

If you’re attending the Immuno-Oncology Summit Europe 2023, we’d love to connect with you! Let’s join forces and shape the future of immuno-oncology together. See you in London! 🗺️🎉

About Scailyte

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. 

Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

Transforming Healthcare with Unmatched Biomarker Discovery Power

Experience the game-changing convergence of AI and healthcare. Join us on this journey as we transla...

Read more

Recent News

LSX Congress USA 2023

Join Scailyte at the LSX Congress USA in Boston on September 13-14 at the Hynes Convention Centre, B...

Read more

Recent News

Unveiling ScaiVision's Clinical Potential

Embarking on the last leg of our Discovery Potential series, we're delving into ScaiVision's incredi...

Read more

Recent News

ScaiDigest Volume 3: Unveiling Immuno-Oncology's Next Frontier

In Volume 3, our very own Diana Stoycheva takes the helm to explore the fascinating realm of single-...

Read more

Recent News

Revolutionizing Biomarker Discovery: Unlock the Power of Scailyte's AI platform

Dive into the forefront of scientific advancement with Scailyte's groundbreaking AI platform, ScaiVi...

Read more

Recent News

Empowering Precision Healthcare with Unparalleled Discovery Potential

From revealing hidden insights to transforming healthcare, ScaiVision is rewriting the rules of disc...

Read more

Recent News

Accelerating Discoveries with Scailyte's Speed Strength

In the world of clinical research and development, time is of the essence. Our mission at Scailyte i...

Read more

Recent News

Nurturing Wellbeing in Our Workspace: Prioritizing People's Growth

At Scailyte, our commitment to ESG goes beyond numbers. It extends to every individual within our vi...

Read more

Recent News

01 /04

Transforming Healthcare with Unmatched Biomarker Discovery Power

Experience the game-changing convergence of AI and healthcare. Join us on this journey as we transla...

Read more

LSX Congress USA 2023

Join Scailyte at the LSX Congress USA in Boston on September 13-14 at the Hynes Convention Centre, B...

Read more

Recent News

02 /04

Unveiling ScaiVision's Clinical Potential

Embarking on the last leg of our Discovery Potential series, we're delving into ScaiVision's incredi...

Read more

ScaiDigest Volume 3: Unveiling Immuno-Oncology's Next Frontier

In Volume 3, our very own Diana Stoycheva takes the helm to explore the fascinating realm of single-...

Read more

Recent News

03 /04

Revolutionizing Biomarker Discovery: Unlock the Power of Scailyte's AI platform

Dive into the forefront of scientific advancement with Scailyte's groundbreaking AI platform, ScaiVi...

Read more

Empowering Precision Healthcare with Unparalleled Discovery Potential

From revealing hidden insights to transforming healthcare, ScaiVision is rewriting the rules of disc...

Read more

Recent News

04 /04

Accelerating Discoveries with Scailyte's Speed Strength

In the world of clinical research and development, time is of the essence. Our mission at Scailyte i...

Read more

Nurturing Wellbeing in Our Workspace: Prioritizing People's Growth

At Scailyte, our commitment to ESG goes beyond numbers. It extends to every individual within our vi...

Read more

Recent News